GPT and hepatocellular carcinoma: The most common TEAEs related to EVER4010001 (diarrhea, increased AST, and increased ALT) were the same as the CFGF401X2101 trial treating HCC and solid tumors with EVER4010001 monotherapy and EVER4010001 plus spartalizumab combination therapy.28, 44